Related Experiment Video
Updated: Jun 28, 2025
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic Markers of Cardiovascular Disease
1Department of Pharmacy Practice, Yenepoya Pharmacy College & Research centre, Yenepoya (Deemed to be University), Ayush campus, Naringana, Mangalore, Karnataka, India.
Insights
Genetic biomarkers are crucial for understanding cardiovascular disorders (CVDs). Genetic testing identifies individuals at high risk for heart disease, enabling early intervention and prevention strategies for conditions like coronary artery disease.
Area of Science:
- Genetics and Cardiovascular Medicine
Background:
- Cardiovascular Disorders (CVDs) are a leading global cause of mortality and disability.
- Myocardial infarction accounts for a significant proportion of CVD deaths annually.
- Genetic factors influence key mechanisms in CVD development, including lipid metabolism and blood pressure regulation.
Purpose of the Study:
- To investigate the application of genetic biomarkers in various cardiac disorders.
- To emphasize the role of individual genes and mutations in cardiovascular disease.
- To highlight the importance of genetic testing for risk identification and timely intervention.
Main Methods:
- Review of genetic variations and mutations linked to cardiovascular conditions.
- Analysis of gene functions in blood pressure regulation, lipid metabolism, and cardiac activity.
- Exploration of genetic biomarker applications in coronary artery disease, hypertension, arrhythmias, cardiomyopathy, and heart failure.
Main Results:
- Genetic variations significantly impact lipid metabolism, blood pressure, and heart function.
- These variations increase the risk of obesity, metabolic disorders, and subsequent cardiovascular disease.
- Genetic testing can identify at-risk individuals and families for proactive management.
Conclusions:
- Understanding genetic factors is essential for the identification, management, and prevention of CVDs.
- Genetic biomarkers offer valuable insights into the pathogenesis of cardiac disorders.
- Genetic testing facilitates personalized risk assessment and early intervention strategies for heart disease.
Abstract:
Cardiovascular Disorders (CVDs) are the leading cause mortality in developed as well as developing nations, and has now emerged as one of the leading causes of disability and mortality around the globe. According to the World Health Organization, four out of every five patients with cardiovascular disease die from a myocardial infarction each year. Numerous genes have been linked to coronary artery disease, influencing mechanisms such as blood pressure regulation, lipid metabolism, inflammation, and cardiac activity. Genetic variations or mutations in these genes can affect lipid metabolism, blood pressure management, and heart function, increasing the risk of obesity, metabolic disorders, and resulting in the development of cardiovascular disease. Understanding the role of genes and related complications are essential for the identification, management, and prevention of cardiovascular conditions. Performing a genetic test for variations in the gene may help identify people as well as their families who are at a greater risk of heart disease, which enables risk identification and timely intervention. . This article investigates the applications of genetic biomarkers in cardiac disorders such as coronary artery disease, hypertension, arrhythmias, cardiomyopathy, and heart failure, with an emphasis on individual genes and their effects on mutation.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
01:05Single Nucleotide Polymorphisms-SNPs
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications